missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human LRP-6 Fc Chimera Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Brand: R&D Systems™ 1505-LR-025
4290.17 NOK valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human LRP-6 Fc Chimera Protein is derived from NS0. The Recombinant Human LRP-6 Fc Chimera Protein has been validated for the following applications: Binding Activity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 180 kDa (monomer) | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| <0.1 EU per 1μg of the protein by the LAL method. | |
| Recombinant |
| 4040 | |
| LRP-6 Fc Chimera | |
| Mouse myeloma cell line,NS0-derived human LRP-6 protein, (N-terminus) Human LRP-6 (Ala20-Pro1368) Accession &Num; O75581 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Unconjugated | |
| 80%, by SDS-PAGE under reducing conditions and visualized by silver stain. |